{"id":19132,"date":"2023-03-24T08:44:40","date_gmt":"2023-03-24T08:44:40","guid":{"rendered":"https:\/\/clinlabint.com\/?p=19132"},"modified":"2023-03-24T08:46:32","modified_gmt":"2023-03-24T08:46:32","slug":"fujifilm-irvine-scientific-launches-hek293-feed-specifically-designed-for-viral-vector-production-2","status":"publish","type":"post","link":"https:\/\/clinlabint.com\/fujifilm-irvine-scientific-launches-hek293-feed-specifically-designed-for-viral-vector-production-2\/","title":{"rendered":"FUJIFILM Irvine Scientific launches HEK293 feed, specifically designed for viral vector production"},"content":{"rendered":"
\n

\r\n\"Bio-Rad<\/a>\r\n<\/p>\n<\/div><\/section><\/div>

<\/p>\n<\/div><\/section>
\n

FUJIFILM Irvine Scientific launches HEK293 feed, specifically designed for viral vector production<\/h1>\/ in Product News<\/a> <\/span><\/span><\/header>\n<\/div><\/section>
\n

FUJIFILM Irvine Scientific, a world leader in the development and manufacture of serumfree and chemically defined cell culture media for bioproduction and cell therapy manu-facturing, has introduced its BalanCD HEK293 Viral Feed. The chemically defined, nutrient-based HEK293-specific feed medium is designed to boost adeno-associated viral vector (AAV) production for gene therapy applications and viral vector-based vaccines.<\/strong><\/p>\n

<\/p>\n

Numerous gene therapies have received FDA approval and as more viral vector-based vaccines and gene therapies move into commercialization, the demand for large-scale, efficient viral vector manufacturing is increasing. For manufacturers, it is imperative to boost viral vector production to meet supply demands for vaccine and gene therapy manufacture.<\/p>\n

BalanCD HEK293 Viral Feed is optimized to deliver high titers and improve viral packaging efficiency by up to 67% compared to basal control without viral-specific feed for increased production efficiency. It is chemically defined and formulated to deliver consistent performance while increasing viral vector production in HEK293 cells grown in suspension and at scale.<\/p>\n<\/div><\/section>
\n

\"\"<\/div><\/div><\/div>
\n

\u201cViral vector manufacturing must evolve rapidly to support increased numbers of gene therapies and viral vector-based vaccines being developed and commercialized. We developed BalanCD HEK293 Viral Feed specifically to increase yields and help manufacturers maximize production, and lower cost of goods related to viral vector-based drug programmes,\u201d said Erik Vaessen, chief business officer, FUJIFILM Irvine Scientific.<\/p>\n

BalanCD HEK293 Viral Feed is GMP manufactured using raw materials sourced using a strict raw material and supply chain programme to ensure continuity of supply and lot-to-lot reliability for HEK293-specific applications. It is available in a 500 mL liquid format and made-to-order powder format, and may be used with a wide range of basal growth media.<\/p>\n

For more information, visit: htt<\/em>ps:\/\/www.irvinesci.co<\/em>m<\/em><\/a>.<\/em><\/p>\n

Digital issue: Please click here<\/a> for more information<\/p>\n<\/div><\/section>
\n

\n